Sorted By:

Relevance


Guest Post: The importance of a modern FDA in drug discovery

PhRMA  |  Blog Post

The ITIF report I mentioned notes that, in 1987, it took almost two and a half years on average for the FDA to review a new drug.
http://catalyst.phrma.org/the-importance-of-a-modern-fda-in-drug-discovery

Improved Adherence and Older Americans

PhRMA  |  Graphic

...
https://www.phrma.org/graphic/improved-adherence-and-older-americans

Mental health in the New Era of Medicine

PhRMA  |  Blog Post

The program will be streamed live from 3:00 - 4:30 pm CT/4:00 - 5:30 ET, and those interested can join the conversation on Twitter with @PhRMA and #GoBoldy.
http://catalyst.phrma.org/mental-health-in-the-new-era-of-medicine

Then and Now: How Prescription Drug Prices Fall Significantly Over Time

PhRMA  |  Blog Post

The savings created by generic copies free up resources to invest in new treatments - creating headroom for innovation – and resulting in significant progress against some of the most costly and challenging diseases.
http://catalyst.phrma.org/then-and-now-how-prescription-drug-prices-fall-significantly-over-time

ICYMI: Survey highlights key barriers limiting number and scale of new approaches to paying for medicines

PhRMA  |  Blog Post

Allow a full range of truthful and non-misleading communications between innovators and payers for all medically accepted uses of medicines.
http://catalyst.phrma.org/icymi-survey-highlights-key-barriers-limiting-number-and-scale-of-new-approaches-to-paying-for-medicines

ICYMI: Survey highlights key barriers limiting number and scale of new approaches to paying for medicines

PhRMA  |  Blog Post

Allow a full range of truthful and non-misleading communications between innovators and payers for all medically accepted uses of medicines.
http://catalyst.phrma.org/icymi-survey-highlights-key-barriers-limiting-number-and-scale-of-new-approaches-to-paying-for-medicines

Hepatitis C: Myths & Facts

PhRMA  |  Graphic

...
https://www.phrma.org/graphic/hepatitis-c-myths-and-facts

Aly Rusciano: My Life with Juvenile Arthritis and step therapy

Access Better Coverage  |  From Our Network

I have an amazing doctor who has always been a strong advocate for my family and me, but just recently he moved out of state.
http://www.accessbettercoverage.org/social-news/aly-rusciano-my-life-with-juvenile-arthritis-and-step-therapy

World AIDS Day 2016: A decade of scientific innovation

PhRMA  |  Blog Post

To learn more on how America’s biopharmaceutical research companies are fighting HIV/AIDS, visit www.fromhopetocures.org/fighting-hiv/aids. 
http://catalyst.phrma.org/world-aids-day-2016-a-decade-of-scientific-innovation

New data put medicine costs and spending in context

PhRMA  |  Blog Post

Our industry is committed to working with policymakers to advance solutions that further enhance the private marketplace, lower costs for patients and promote continued medical innovation. 
http://catalyst.phrma.org/new-data-put-medicine-costs-and-spending-in-context

More Than 7,000 Medicines in Development Globally

Chartpack  |  From Our Network

Biopharmaceutical researchers are working on new medicines for many diseases, including diabetes, HIV/AIDS, immunological disorders, and a variety of cancers, among many others.
http://chartpack.phrma.org/biophrma-chartpack/research-and-development/more-than-7-000-medicines-in-development-globally

Video: How can biomarkers and surrogate endpoints enhance R&D of medicines?

PhRMA  |  Blog Post

Read more about proactive policy solutions to modernize the FDA and deliver innovative treatments to patients here.
http://catalyst.phrma.org/video-how-can-biomarkers-and-surrogate-endpoints-enhance-r-and-d-of-medicines

Medicare Part D’s six protected classes

PhRMA  |  Blog Post

Be sure to check out the responses from our contributors and we encourage you to join the Conversation by sharing your thoughts in the comment section.
http://catalyst.phrma.org/medicare-part-d-six-protected-classes

Loretta Shares a Story of Hope in the Face of Her Cancer Diagnosis

PhRMA  |  Blog Post

I will live with this, and I will live well, for the rest of my life.”
http://catalyst.phrma.org/loretta-shares-a-story-of-hope-in-the-face-of-her-cancer-diagnosis

Innovator Dialogue: New Era of Medicine with Brigham and Women’s Hospital

PhRMA  |  Video

Joseph Loscalzo, chair of the Department of Medicine and physician-in-chief at Brigham and Women’s Hospital to talk about life-changing innovation - from scientific discovery in a lab all the way to the delivery of therapies that comfort and treat patients.
https://www.phrma.org/video/innovator-dialogue-new-era-of-medicine-with-brigham-and-women-s-hospital

New Era of Medicine: Vaccines

PhRMA  |  From PhRMA

A robust pipeline containing new vaccine technology has the potential to prevent the transmission of the human immunodeficiency virus (HIV), protect against malaria, and treat pancreatic cancer.
https://www.phrma.org

Fighting High Cholesterol

PhRMA  |  Graphic

...
https://www.phrma.org/graphic/fighting-high-cholesterol

Partnership for Prescription Assistance Adds New Feature to Website to Help America’s Uninsured Access Information about Medicaid and CHIP

PhRMA  |  Press Release

“In the meantime, the PPA will continue to be available as a critical resource for financially-struggling Americans who need help accessing health care services and treatments.” 
https://www.phrma.org/press-release/partnership-for-prescription-assistance-adds-new-feature-to-website-to-help-america-s-uninsured-access-information-about-medicaid-and-chip

Partnership for Prescription Assistance Celebrates Five Year Anniversary and Launch of ‘PPA 2.0’

PhRMA  |  Press Release

“At a time when the national unemployment rate is at one of its highest in almost two decades, PPA has become an important lifeline for a growing number of patients,” PhRMA’s Johnson said.
https://www.phrma.org/press-release/partnership-for-prescription-assistance-celebrates-five-year-anniversary-and-launch-of-ppa-2-0

ICYMI: More than 60 PhRMA company scientists visit Capitol Hill

PhRMA  |  Blog Post

To learn more about the men and women of America’s biopharmaceutical research companies, visit: http://www.fromhopetocures.org/science Lilly scientists met with @RepToddYoung today to chat about their work and the importance of health .com/hashtag/innovation?
http://catalyst.phrma.org/icymi-more-than-60-phrma-company-scientists-visit-capitol-hill

Intellectual Property

PhRMA  |  From PhRMA

However, many countries, including nations like Canada, China, and India, embrace IP systems that discourage medical innovation by not providing adequate protections, ultimately diminishing patient access to new treatments and cures.
https://www.phrma.org/advocacy/intellectual-property

Medicare Monday: Study finds mortality rates for elderly have decreased every year since creation of Part D

PhRMA  |  Blog Post

Learn more about how Medicare Part D controls costs, improves health and saves lives here.
http://catalyst.phrma.org/medicare-monday-study-finds-mortality-rates-for-elderly-have-decreased-every-year-since-creation-of-part-d

Medicare Monday: New research finds trends in Average Sales Price of Part B drugs remains stable

PhRMA  |  Blog Post

The Moran analysis also suggests “the cost of prescription medicines covered by Medicare Part B is influenced by broader marketplace dynamics that drive changes in the mix of brand and generic drugs used by patients,” calling attention to the flaws of looking at trends in pricing for individual products and ignoring the impact of generics and other competitive pressures.
http://catalyst.phrma.org/medicare-monday-new-research-finds-trends-in-average-sales-price-of-part-b-drugs-remains-stable

PhRMA CEO in Forbes - How to negotiate better deals for prescription medicines

PhRMA  |  Blog Post

Companies are also considering new ways to pay for treatment when a patient needs multiple high-priced innovative medicines and experimenting with money-back guarantees if a medicine does not work as intended.
http://catalyst.phrma.org/phrma-ceo-in-forbes-how-to-negotiate-better-deals-for-prescription-medicines

Trade Facilitation and Enforcement Act will strengthen IP enforcement

PhRMA  |  Blog Post

The new position at USTR will help promote strong rules abroad that protect American innovations and the many jobs they support.
http://catalyst.phrma.org/trade-facilitation-and-enforcement-act-will-strengthen-ip-enforcement

You have reviewed the first 250 results out of 2649. Each page contains 25 results. You're on page 10.

prev 7 8 9 10 11 12 next